Figure S1.
DT-treated CCL3-EASER mice are more susceptible to mCMV infection. (A) Scheme of the experiment. C57BL6/J (BL6) and CCL3-EASER mice were treated with DT or PBS, and infected 1 day later with mCMV. (B) Survival plot of PBS- or DT-treated CCL3-EASER and BL6 mice. (C) Relative body weight of the indicated mice. (D) mCMV genome counts in liver, spleen, and lung at 14 days after infection. (E) Liver mCMV viral titer at 14 days after infection. Data shows mean ± SD is representative of at least three mice per group.